Dana-Farber Research Advances Lead to FDA Label Update for Primary CNS Lymphoma
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
Tag: immune effector cell-associated neurotoxicity syndrome
Advancements in CAR T-Cell Therapy Neurotoxicity Insights
In recent years, CAR T-cell therapy has emerged as a groundbreaking approach in treating various hematological malignancies, significantly influencing the ...
Understanding Neurological Risks in CAR T-Cell Therapy
In recent years, the advent of genetically engineered chimeric antigen receptor (CAR) T cell therapy has revolutionized the landscape of ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!